StreetInsider.com News Articles

MiMedx Group (MDXG) PT Raised to $8 at Craig-Hallum

Thu, 27 Aug 2026 09:16:08 -0400

Craig-Hallum analyst Chase Knickerbocker raised the price target on MiMedx Group (NASDAQ: MDXG) to $8.00 (from $6.00) while maintaining a Buy rating.

Form S-4 MIMEDX GROUP, INC.

Tue, 25 Aug 2026 06:01:00 -0400

http://archive.fast-edgar.com/20260825/AA2ZI22CLZ22G29222ZM2CY2SLNPZ222Y68Q

Filed on: August 25, 2026

Form S-4 MIMEDX GROUP, INC.

Tue, 25 Aug 2026 06:01:00 -0400

http://archive.fast-edgar.com/20260825/AA2ZI22CLZ22G29222ZM2CY2SLNPZ222Y68Q

Filed on: August 25, 2026

MiMedx Group (MDXG) Reiterated at Overweight by Cantor Fitzgerald: Wound Care Market Stable

Mon, 17 Aug 2026 08:00:02 -0400

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $8.00 price target on MiMedx Group (NASDAQ: MDXG).

The analyst commented, "We are encouraged by the early signs of stabilization in the Wound Care market & synergistic acquisition in Surgical Care. 2Q26 updates around Wound Care support our thesis, driven by our payor coverage, that the market can recover from reimbursement pressures. MDXG believes it is seeing early signs of stabilization as volumes increased 22% Q/Q & 44% Q/ Q in centers where MDXG has concentrated its efforts. The proposed 2027 physician fee schedule failed to correct these pressures, but MDXG

Form 8-K/A MIMEDX GROUP, INC. For: Jul 29

Tue, 11 Aug 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260811/26906643.html

Form 8-K/A MIMEDX GROUP, INC. For: Jul 29

Tue, 11 Aug 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260811/26906643.html

H.C. Wainwright Downgrades Sanara MedTech (SMTI) to Neutral

Thu, 30 Jul 2026 06:39:13 -0400

(Updated - July 30, 2026 6:39 AM EDT)

H.C. Wainwright analyst Yi Chen downgraded Sanara MedTech (NASDAQ: SMTI) from Buy to Neutral.

The analyst comments "MiMedx to acquire Sanara at $350M enterprise value in a cash and stock transaction. Yesterday, MiMedx Group (MDXG; not rated) and Sanara MedTech announced that they have entered into a definitive merger agreement under which MiMedx will acquire all the outstanding shares of Sanara in a cash and stock transaction valued at $35 ($33 in cash and 0.4735 share of MDXG common stock) per Sanara share with a total enterprise value of approximately $350M. According to management,

H.C. Wainwright Downgrades Sanara MedTech (SMTI) to Neutral

Thu, 30 Jul 2026 06:39:13 -0400

(Updated - July 30, 2026 6:39 AM EDT)

H.C. Wainwright analyst Yi Chen downgraded Sanara MedTech (NASDAQ: SMTI) from Buy to Neutral.

H.C. Wainwright Downgrades Sanara MedTech (SMTI) to Neutral

Thu, 30 Jul 2026 06:39:13 -0400

(Updated - July 30, 2026 6:39 AM EDT)

H.C. Wainwright analyst Yi Chen downgraded Sanara MedTech (NASDAQ: SMTI) from Buy to Neutral.

H.C. Wainwright Downgrades Sanara MedTech (SMTI) to Neutral

Thu, 30 Jul 2026 06:39:13 -0400

(Updated - July 30, 2026 6:39 AM EDT)

H.C. Wainwright analyst Yi Chen downgraded Sanara MedTech (NASDAQ: SMTI) from Buy to Neutral.

MiMedx Group (MDXG) Misses Q2 EPS by 3c

Wed, 29 Jul 2026 16:57:56 -0400

MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $64 million versus the consensus estimate of $63.45 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

Form 8-K MIMEDX GROUP, INC. For: Jul 29

Wed, 29 Jul 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260729/26835013.html

Form 8-K MIMEDX GROUP, INC. For: Jul 29

Wed, 29 Jul 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260729/26835013.html

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

Joseph H. Capper, MIMEDX Chief Executive Officer, commented, "During the second quarter, we delivered another strong performance in our Surgical franchise, with 15% year-over-year revenue growth balanced

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Wed, 29 Jul 2026 16:07:00 -0400

Reports Second Quarter Net Sales of $64 Million

Reiterates Full Year Financial Outlook on a Standalone Basis

Announces Plans to Acquire Sanara MedTech

Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET

MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.